355 related articles for article (PubMed ID: 16552236)
41. Radiotherapy for head and neck cancer: latest developments and future perspectives.
Bernier J; Bentzen SM
Curr Opin Oncol; 2006 May; 18(3):240-6. PubMed ID: 16552235
[TBL] [Abstract][Full Text] [Related]
42. Novel chemotherapeutic and targeted agents in metastatic colorectal cancer: the time has arrived.
O'Neil BH; Goldberg RM
Expert Opin Investig Drugs; 2003 Dec; 12(12):1939-49. PubMed ID: 14640938
[TBL] [Abstract][Full Text] [Related]
43. Emerging role of EGFR-targeted therapies and radiation in head and neck cancer.
Song J; Chen C; Raben D
Oncology (Williston Park); 2004 Dec; 18(14):1757-67; discussion 1767, 1771-2, 1777. PubMed ID: 15700625
[TBL] [Abstract][Full Text] [Related]
44. Cetuximab in non-melanoma skin cancer.
Wollina U
Expert Opin Biol Ther; 2012 Jul; 12(7):949-56. PubMed ID: 22519406
[TBL] [Abstract][Full Text] [Related]
45. Cetuximab in squamous cell carcinoma of the head and neck.
Hitt R; Martín P; Hidalgo M
Future Oncol; 2006 Aug; 2(4):449-57. PubMed ID: 16922611
[TBL] [Abstract][Full Text] [Related]
46. Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors.
Sartor CI
Nat Clin Pract Oncol; 2004 Dec; 1(2):80-7. PubMed ID: 16264825
[TBL] [Abstract][Full Text] [Related]
47. EGFR-antibody-supplemented TPF chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatment.
Knecht R; Peters S; Hambek M; Solbach C; Baghi M; Gstöttner W; Hambek M
Adv Otorhinolaryngol; 2005; 62():81-91. PubMed ID: 15608420
[TBL] [Abstract][Full Text] [Related]
48. Pharmacotherapy of head and neck squamous cell carcinoma.
Pan Q; Gorin MA; Teknos TN
Expert Opin Pharmacother; 2009 Oct; 10(14):2291-302. PubMed ID: 19663637
[TBL] [Abstract][Full Text] [Related]
49. Molecular therapy of head and neck cancer.
Modjtahedi H
Cancer Metastasis Rev; 2005 Jan; 24(1):129-46. PubMed ID: 15785877
[TBL] [Abstract][Full Text] [Related]
50. New cytotoxic and molecular-targeted therapies of head and neck tumors.
Caponigro F; Ionna F; Comella G
Curr Opin Oncol; 2004 May; 16(3):225-30. PubMed ID: 15069317
[TBL] [Abstract][Full Text] [Related]
51. Stepwise progress in epidermal growth factor receptor/radiation studies for head and neck cancer.
Harari PM
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S25-7. PubMed ID: 17848286
[TBL] [Abstract][Full Text] [Related]
52. Monoclonal antibodies targeting epidermal growth factor receptor and vascular endothelial growth factor with a focus on head and neck tumors.
Caponigro F; Formato R; Caraglia M; Normanno N; Iaffaioli RV
Curr Opin Oncol; 2005 May; 17(3):212-7. PubMed ID: 15818163
[TBL] [Abstract][Full Text] [Related]
53. Molecular targeted therapies in all histologies of head and neck cancers: an update.
Razak AR; Siu LL; Le Tourneau C
Curr Opin Oncol; 2010 May; 22(3):212-20. PubMed ID: 20173639
[TBL] [Abstract][Full Text] [Related]
54. New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancer.
Awada A
Forum (Genova); 2002; 12(1):4-15. PubMed ID: 12634907
[TBL] [Abstract][Full Text] [Related]
55. Targeted radionuclide therapy in head and neck cancer.
Nestor MV
Head Neck; 2010 May; 32(5):666-78. PubMed ID: 19827126
[TBL] [Abstract][Full Text] [Related]
56. [Anti-angiogenesis - a therapy concept in the treatment of head and neck carcinomas? A review].
Riedel F; Hörmann K
Laryngorhinootologie; 2001 Sep; 80(9):535-41. PubMed ID: 11555787
[TBL] [Abstract][Full Text] [Related]
57. Integrating novel agents into the curative treatment of head and neck cancer.
Haddad R; Allen A; Wirth L; Tishler R; Posner M
Expert Rev Anticancer Ther; 2006 Feb; 6(2):157-9. PubMed ID: 16445367
[No Abstract] [Full Text] [Related]
58. Update on novel therapeutic agents for cervical cancer.
del Campo JM; Prat A; Gil-Moreno A; Pérez J; Parera M
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S72-6. PubMed ID: 18544460
[TBL] [Abstract][Full Text] [Related]
59. Drug interactions among the epidermal growth factor receptor inhibitors, other biologics and cytotoxic agents.
Visentin M; Biason P; Toffoli G
Pharmacol Ther; 2010 Oct; 128(1):82-90. PubMed ID: 20542058
[TBL] [Abstract][Full Text] [Related]
60. [Recent advances in molecular-targeted drugs in head and neck cancer].
Tahara M
Gan To Kagaku Ryoho; 2008 May; 35(5):745-52. PubMed ID: 18487911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
